Last reviewed: June 11, 2026
Last updated: June 11, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonist medications have become a cornerstone of modern weight management and diabetes care, with clinical trials showing average weight reductions of 15-22% over 68 weeks. However, not every person meets the same criteria for starting these medications, and understanding the requirements helps you and your healthcare provider make an informed decision. PlexusDx specializes in personalized GLP-1 therapy tailored to your specific metabolic needs and genetic profile.
Medical Eligibility Criteria for GLP-1 Therapy
GLP-1 medications are prescribed for two primary conditions: type 2 diabetes and weight management in adults with obesity or excess weight. For diabetes treatment, you typically need a confirmed diagnosis of type 2 diabetes and may be eligible if metformin alone or other first-line agents haven't achieved target blood sugar levels. For weight loss, FDA-approved indications generally require a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as hypertension, sleep apnea, or cardiovascular disease.
Your medical history matters significantly when determining GLP-1 suitability. Healthcare providers screen for personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, severe kidney disease, or active pancreatitis—conditions that may contraindicate GLP-1 use. A full medication review ensures no dangerous interactions, and assessment of your current blood pressure and heart rate establishes a safe baseline before therapy begins.
How Dosing Requirements Work with GLP-1 Injections
GLP-1 therapy typically begins at a low starting dose to allow your body to adjust and minimize gastrointestinal side effects. With semaglutide injections, dosing often initiates at 0.25 mg weekly, advancing gradually over four to eight weeks based on your tolerance and metabolic response. Each dose adjustment is individualized—some people reach therapeutic benefit at lower doses, while others require escalation to maximize weight loss or blood sugar control. Your dose may need to go up based on your response, but PlexusDx pricing remains flat, so dose adjustments never increase your monthly cost.
The requirement for dose titration means regular follow-up appointments and honest communication about side effects and appetite suppression levels. Many patients find that their optimal dose stabilizes after 12 to 16 weeks of treatment, and some remain on maintenance doses indefinitely while others taper as lifestyle changes compound the medication's effects. PlexusDx compounded semaglutide injections start at $149 per month across all commitment tiers, eliminating concerns about escalating costs as your therapy advances.
Baseline Labs and Testing Requirements
Before initiating GLP-1 therapy, PlexusDx requires baseline bloodwork to assess kidney function, liver health, and pancreatic enzymes. A fasting glucose level or hemoglobin A1c test establishes your starting point for diabetes management, while a comprehensive metabolic panel ensures your kidneys handle the medication safely. These tests aren't optional—they form the foundation of personalized, safe treatment and protect you from preventable complications.
The Precision Peptide Genetic Test is an optional add-on ($99 after your first month of treatment) that maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights. This test examines key variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 to identify which GLP-1 compound and formulation may work best for your unique biology. Understanding your genetic predispositions to appetite regulation and metabolic efficiency helps optimize therapy from the start.
Ongoing Monitoring and Management Requirements
GLP-1 therapy is not a set-and-forget treatment; it requires consistent monitoring to ensure safety and efficacy. You'll need periodic check-ins every 4 to 12 weeks depending on your dose escalation phase, during which your weight, blood pressure, and tolerance are assessed. If you have diabetes, regular hemoglobin A1c testing tracks glucose control, typically every three months during the first year and every six months thereafter once stable. Gastrointestinal symptoms, appetite changes, and any signs of injection-site reactions are documented and addressed.
Long-term GLP-1 use also requires vigilance for rare but serious side effects including pancreatitis (severe abdominal pain), gallbladder issues, or thyroid concerns. You're expected to report any unusual symptoms immediately and maintain open communication with your healthcare provider. PlexusDx serves all 50 states and requires no insurance or membership fees, making continuous access and follow-up care affordable and convenient for long-term management.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I need a specific BMI to qualify for GLP-1 weight loss therapy?
General eligibility includes a BMI of 30 or higher, or 27 or higher with a weight-related health condition. PlexusDx evaluates your individual health profile during the intake process to determine suitability, and a healthcare provider reviews your medical history before prescribing.
What happens if GLP-1 doesn't work for my weight loss after three months?
If you're not seeing results after adequate time on a stable dose, your provider may adjust your dose further, switch compounds, or explore alternative therapies. PlexusDx offers both semaglutide and tirzepatide, as well as dual-compound options, ensuring flexibility if one approach underperforms for your metabolism.
Will my insurance cover PlexusDx GLP-1 medications?
PlexusDx requires no insurance and no membership fees—all medications are available directly to you. Your treatment is HSA and FSA eligible, and compounded medications from our licensed 503A pharmacies are typically less expensive than brand-name alternatives, making personalized GLP-1 therapy financially accessible.
Are there any serious side effects I should watch for while on GLP-1?
Common side effects are nausea and appetite suppression, which usually improve over time. Serious but rare complications include pancreatitis, gallbladder disease, and thyroid issues. Baseline labs and ongoing monitoring catch problems early, and you should report severe abdominal pain, persistent vomiting, or vision changes immediately to your provider.
How does the Precision Peptide Genetic Test improve my GLP-1 outcome?
The Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genes to reveal your metabolic predispositions and peptide-pathway responsiveness. This genetic insight helps PlexusDx recommend whether semaglutide, tirzepatide, or a dual-compound approach may work best for your unique biology, optimizing results from the start.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Ozempic Help Lose Visceral Fat?
Can You Take Ozempic With Sertraline? Navigating Weight Loss and Mental Well-being